Theriana Pharmaceuticals, Inc. — Form D
Theriana Pharmaceuticals, Inc. of WALTHAM, MA, a company, filed a Form D exempt-offering notice with the SEC on 2017-07-05. The offering totals $7.0M, of which $1.8M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2017-07-05
- Form: D
- Accession: 0001710617-17-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $7.0M
- Amount sold: $1.8M
- Remaining: $5.3M
- Investors: 2
- Date of first sale: 2017-06-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-289970
Issuer
- Name: Theriana Pharmaceuticals, Inc.
- CIK: 0001710617
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: C/O FABER DAEUFER & ITRATO PC, WALTHAM, MA, 02451
- Phone: 781-795-4723
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Daniel S Grau | Director | Arlington, MA |
| Daniel S Grau | Executive Officer | Arlington, MA |
More